Which has the lower trailing P/E, LQDA or PRVA?

LQDA has the lower trailing P/E: LQDA trades at 18.92 and PRVA at 93.50. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, LQDA or PRVA?

Over the past five years, LQDA grew revenue faster — LQDA at a 128.77% CAGR versus PRVA at 22.35%.

Is LQDA or PRVA more profitable?

LQDA runs the higher net margin — LQDA at 30.74% versus PRVA at 1.19%.

How have LQDA and PRVA total returns compared?

Over the past 5 years, LQDA delivered 59.01% and PRVA delivered -1.30% annualized total return. Past performance doesn't predict future results.

Liquidia Corporation (LQDA) vs Privia Health Group, Inc. (PRVA)

A side-by-side comparison of Liquidia Corporation and Privia Health Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

LQDA

Liquidia Corporation

$2.30B

$25.91HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

PRVA

Privia Health Group, Inc.

$2.56B

$20.28HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — LQDA vs PRVA

growth of $100 · dividends reinvested · last 5y

LQDA +856.4% (+57.1%/yr)PRVA -11.1% (-2.3%/yr)LQDA compounded faster over this window

Log scale — wide-divergence pair

LQDA PRVA

LQDA vs PRVA: by the numbers

•PRVA is the larger company ($2.56B vs $2.30B market cap).
•LQDA trades at the lower trailing earnings multiple (18.92 vs 93.50 P/E), one valuation lens rather than an overall verdict.
•LQDA converts more revenue to profit (30.74% vs 1.19% net margin).
•LQDA grew revenue faster over the past five years (128.77% vs 22.35% CAGR).

Metrics side by side

Valuation

Metric	LQDA	PRVA
P/E ratio	18.92	93.50
Forward P/E	10.42	78.74
P/S ratio	5.11	1.08
P/B ratio	11.81	0.00
EV / EBITDA	12.62	N/A
FCF yield	2.63%	N/A

Profitability

Metric	LQDA	PRVA
Gross margin	92.48%	7.61%
Operating margin	-32.45%	1.90%
Net margin	30.74%	1.19%
ROE	71.04%	0.00%
ROIC	46.99%	0.00%

Growth (annualized)

Metric	LQDA	PRVA
Revenue CAGR (5Y)	128.77%	22.35%
EPS CAGR (5Y)	N/A	-8.73%
Total return CAGR (5Y)	59.01%	-1.30%

Frequently asked

Which has the lower trailing P/E, LQDA or PRVA?: LQDA has the lower trailing P/E: LQDA trades at 18.92 and PRVA at 93.50. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, LQDA or PRVA?: Over the past five years, LQDA grew revenue faster — LQDA at a 128.77% CAGR versus PRVA at 22.35%.
Is LQDA or PRVA more profitable?: LQDA runs the higher net margin — LQDA at 30.74% versus PRVA at 1.19%.
How have LQDA and PRVA total returns compared?: Over the past 5 years, LQDA delivered 59.01% and PRVA delivered -1.30% annualized total return. Past performance doesn't predict future results.

Go deeper

Full LQDA analysis Full PRVA analysis Interactive comparison tool

Dig into the metrics

Liquidia P/E ratio Privia Health P/E ratio Liquidia ROE Privia Health ROE Liquidia operating margin Privia Health operating margin Liquidia revenue growth Privia Health revenue growth Liquidia free cash flow Privia Health free cash flow

Liquidia & Privia Health appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.